Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ - Related Studies

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

This study is ongoing, but not recruiting participants.

Study NCT00438659. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer
		Cancer-Related Problem/Condition

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Carcinoma in Situ
		Carcinoma, Intraductal, Noninfiltrating
		Dermatitis
		Radiodermatitis

3	More general conditions related to this trial
		Adenocarcinoma
		Breast Diseases
		Carcinoma
		Disorders of Environmental Origin
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Ductal, Lobular, and Medullary
		Neoplasms, Glandular and Epithelial
		Radiation Injuries
		Skin Diseases
		Wounds and Injuries

4	Interventions listed in this trial
		mometasone furoate
		placebo

5	More general drug interventions related to this trial
		Anti-Allergic Agents
		Anti-Inflammatory Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		North Central Cancer Treatment Group
		National Cancer Institute (NCI)